Saadh M, Jasim N, Ahmed M, Ballal S, Kumar A, Atteri S
Clin Exp Med. 2025; 25(1):66.
PMID: 39998742
PMC: 11861128.
DOI: 10.1007/s10238-025-01600-7.
Iyengar R, Fleifil S, Aaberg M, Yu G, Patel T, Powell C
Clin Ophthalmol. 2025; 18:4019-4028.
PMID: 39741795
PMC: 11687090.
DOI: 10.2147/OPTH.S472071.
Gawecki M, Kicinski K, Bianco L, Battaglia Parodi M
Diagnostics (Basel). 2024; 14(1).
PMID: 38201340
PMC: 10802854.
DOI: 10.3390/diagnostics14010031.
Lin Z, Deng A, Hou N, Gao L, Zhi X
Front Endocrinol (Lausanne). 2023; 14:1108394.
PMID: 36936172
PMC: 10018161.
DOI: 10.3389/fendo.2023.1108394.
Torp T, Kawasaki R, Wong T, Peto T, Grauslund J
BMJ Open Ophthalmol. 2021; 6(1):e000661.
PMID: 33786381
PMC: 7986874.
DOI: 10.1136/bmjophth-2020-000661.
Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in India.
Nair U, Gupta V, Sharma M, Joshi S, Sudhalkar A, Altangerel U
BMC Ophthalmol. 2020; 20(1):405.
PMID: 33036583
PMC: 7545916.
DOI: 10.1186/s12886-020-01630-7.
Different lasers and techniques for proliferative diabetic retinopathy.
Moutray T, Evans J, Lois N, Armstrong D, Peto T, Azuara-Blanco A
Cochrane Database Syst Rev. 2018; 3:CD012314.
PMID: 29543992
PMC: 6494342.
DOI: 10.1002/14651858.CD012314.pub2.
STAT3-mediated activation of is involved in down-regulation of TIMP3 and neovascularization in the ischemic retina.
Gutsaeva D, Thounaojam M, Rajpurohit S, Powell F, Martin P, Goei S
Oncotarget. 2017; 8(61):103568-103580.
PMID: 29262585
PMC: 5732751.
DOI: 10.18632/oncotarget.21592.
Comparison of Efficacy and Side Effects of Multispot Lasers and Conventional Lasers for Diabetic Retinopathy Treatment.
Celiker H, Bulut A, Sahin O
Turk J Ophthalmol. 2017; 47(1):34-41.
PMID: 28182169
PMC: 5282539.
DOI: 10.4274/tjo.75032.
Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.
Rajavi Z, Safi S, Javadi M, Azarmina M, Moradian S, Entezari M
J Ophthalmic Vis Res. 2016; 11(4):394-414.
PMID: 27994809
PMC: 5139552.
DOI: 10.4103/2008-322X.194131.
A Computational Model of Peripheral Photocoagulation for the Prevention of Progressive Diabetic Capillary Occlusion.
Gast T, Fu X, Gens J, Glazier J
J Diabetes Res. 2016; 2016:2508381.
PMID: 27847828
PMC: 5099465.
DOI: 10.1155/2016/2508381.
Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
Boynton G, Stem M, Kwark L, Jackson G, Farsiu S, Gardner T
Ophthalmology. 2015; 122(5):957-67.
PMID: 25601533
PMC: 4414692.
DOI: 10.1016/j.ophtha.2014.12.001.
Laser photocoagulation for proliferative diabetic retinopathy.
Evans J, Michelessi M, Virgili G
Cochrane Database Syst Rev. 2014; (11):CD011234.
PMID: 25420029
PMC: 6823265.
DOI: 10.1002/14651858.CD011234.pub2.
Ultra widefield fundus imaging for diabetic retinopathy.
Kiss S, Berenberg T
Curr Diab Rep. 2014; 14(8):514.
PMID: 24935049
DOI: 10.1007/s11892-014-0514-0.
Change in subfoveal choroidal thickness after argon laser panretinal photocoagulation.
Cho G, Cho H, Kim Y
Int J Ophthalmol. 2013; 6(4):505-9.
PMID: 23991387
PMC: 3755312.
DOI: 10.3980/j.issn.2222-3959.2013.04.18.
Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.
Stem M, Gardner T
Curr Med Chem. 2013; 20(26):3241-50.
PMID: 23745549
PMC: 4071765.
DOI: 10.2174/09298673113209990027.
Visually evoked potentials after panretinal photocoagulation in omani patients with uncontrolled diabetes mellitus.
Shenoy R, Al-Belushi H, Al-Ajmi S, Al-Nabhani S, Ganguly S, Bialasiewicz A
Middle East Afr J Ophthalmol. 2011; 15(2):51-6.
PMID: 21346837
PMC: 3038108.
DOI: 10.4103/0974-9233.51992.
A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.
Xu Y, Zhao H, Zheng Y, Gu Q, Ma J, Xu X
Mol Vis. 2010; 16:1982-95.
PMID: 21031024
PMC: 2956696.
Macular function assessed with mfERG before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy.
Lovestam-Adrian M, Andreasson S, Ponjavic V
Doc Ophthalmol. 2005; 109(2):115-21.
PMID: 15881256
DOI: 10.1007/s10633-004-4862-y.